Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases - Poll - MDSpire

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

  • By

  • Arianna Dal Buono

  • Olga Maria Nardone

  • Rocio Ferreiro-Iglesias

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

  • by Arianna Dal Buono, Olga Maria Nardone, Rocio Ferreiro-Iglesias

  • June 17, 2026

Related Content

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database

Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation